LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.25 USD -0.79% Market Closed
Market Cap: 32.9m USD

Operating Margin
LAVA Therapeutics NV

-381.8%
Current
-476%
Average
-5.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-381.8%
=
Operating Profit
-28m
/
Revenue
7.3m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
NL
LAVA Therapeutics NV
NASDAQ:LVTX
32.9m USD
-382%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
344.4B USD
29%
US
Amgen Inc
NASDAQ:AMGN
156.2B USD
22%
US
Gilead Sciences Inc
NASDAQ:GILD
132.7B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
130.9B USD
40%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
122.2B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
65.6B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.6B EUR
-1%

LAVA Therapeutics NV
Glance View

Market Cap
32.9m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.05 USD
Undervaluation 39%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-381.8%
=
Operating Profit
-28m
/
Revenue
7.3m
What is the Operating Margin of LAVA Therapeutics NV?

Based on LAVA Therapeutics NV's most recent financial statements, the company has Operating Margin of -381.8%.

Back to Top